greeksoup/ stock research
Stock research / United States / KMB · Converted Paper & Paperboard Prods (No Contaners/Boxes) · Nasdaq

Kimberly Clark Corp. (KMB)

Kimberly-Clark was founded in 1872 and incorporated in Delaware in 1928. It manufactures and markets products made from natural or synthetic fibres and materials, using technologies in fibres, nonwovens and absorbency, and sells them in more than 175 countries and territories. Its brands include Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, which hold number one or number two share positions in approximately 70 countries. They sit in five daily-need categories: Baby and Child Care, Adult Care, Feminine Care, Family Care and Professional.

Kimberly Clark Corp.

Kimberly-Clark was founded in 1872 and incorporated in Delaware in 1928. It manufactures and markets products made from natural or synthetic fibres and materials, using technologies in fibres, nonwovens and absorbency, and sells them in more than 175 countries and territories. Its brands include Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, which hold number one or number two share positions in approximately 70 countries. They sit in five daily-need categories: Baby and Child Care, Adult Care, Feminine Care, Family Care and Professional.

Two deals in flight

On 2 November 2025 the company signed a merger agreement to acquire the outstanding equity of the consumer health company Kenvue for stock and cash, approved by both boards, with each Kenvue share converting into 0.14625 Kimberly-Clark shares plus a fixed cash amount, funded from cash on hand, new debt and proceeds of the transaction below. On 5 June 2025 it announced a joint venture with Suzano holding substantially all of the operations of its former International Family Care and Professional segment, in which the Suzano buyer takes a 51% interest and Kimberly-Clark keeps 49%. The filing states that closing is expected in mid-2026, once consultation requirements and regulatory approvals are met. Those results are reported as discontinued operations and excluded from continuing operations and segment results for every period shown.

Segments

Continuing operations are organised into two reportable segments defined by geography, North America and International Personal Care. Certain operations and commercial activities of the former segment that the company kept now sit inside those two. Corporate and Other carries the parts of the former segment sold before the joint venture, along with costs that were once allocated to it but do not belong to the transferred operations.

Powering Care

The 2024 Transformation Initiative was announced in fiscal 2024 to create a more agile and focused operating model, and with it the Powering Care strategy. It rests on three pillars: investing in science-based and proprietary technology to meet unmet and evolving consumer needs, reworking the margin structure and building a fast, adaptable, integrated supply chain with greater visibility, and organising for agility, speed and focused execution.

Selling and supply

Household products are sold directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores and other retail outlets, and through distributors and e-commerce. Professional products go through distributors and directly to manufacturing, lodging, office buildings, food service and high-volume public facilities. Walmart, the largest customer, was approximately 16% of net sales from continuing operations in 2025 and 2024 and 15% in 2023, mostly in North America. Cellulose fibre, as kraft pulp or recycled from recovered waste paper, is the primary raw material for tissue products, and as fluff pulp it is a component of disposable diapers, training and youth pants, feminine pads and incontinence care products. Polypropylene and other synthetics and chemicals are the primary raw materials for the nonwoven fabrics used in those products, with superabsorbent materials in diapers, pants and incontinence care. Competition runs on brand recognition and loyalty, product quality and performance, price, and marketing and distribution capability.

Portfolio moves and people

The company sold its personal protective equipment business, holding the Kimtech and KleenGuard brands, in 2024. In 2023 it bought the remaining shares of Thinx, in reusable period and incontinence underwear, and sold the Neve tissue brand and related consumer and professional tissue assets in Brazil. There were approximately 36,000 employees at 31 December 2025 across consolidated operations, including the business reported as discontinued, approximately 35% of them in North America and the rest spread across approximately 55 countries. Approximately 50% of the workforce was directly involved in manufacturing and distribution.

From Kimberly-Clark's annual report on Form 10-K for the year ended 31 December 2025. The filing

Compare with another name What $10,000 in Kimberly Clark became

Latest results

Latest quarterQ3 FY2026ended 30 September 2026 · 10-Q filed 5 November 2026
Revenue
$4.1 billion
-0.4% on the year · -1.3% on the quarter
Q4 FY2024Q3 FY2026
Net income
$1.8 billion
+302.0% on the year · +419.7% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$5.37
+300.7% on the year · +416.3% on the quarter
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Read the Q3 FY2026 results →the 10-Q on EDGAR ↗
Last full yearFY2025ended 31 December 2025 · 10-K filed 12 February 2026
Revenue
$16.4 billion
-2.1% on the year
FY2018FY2025
Net income
$2.0 billion
-20.6% on the year
FY2018FY2025
Diluted EPS
$6.07
-19.6% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in wordsKimberly Clark (KMB) reported revenue of $16.4 billion for fiscal 2025, the year ended 31 December 2025, down 2.1% on the year before. Net income was $2.0 billion and diluted earnings per share $6.07. Revenue was $16.8 billion in fiscal 2024, $17.1 billion in fiscal 2023, $17.0 billion in fiscal 2022 and $19.4 billion in fiscal 2021. Net income in the same years was $2.5 billion, $1.8 billion, $1.9 billion and $1.8 billion. Over the twelve months to 30 September 2026, Kimberly Clark reported revenue of $16.6 billion and net income of $3.3 billion. Revenue fell 3.0% a year, compounded, over the five years to fiscal 2025. Kimberly Clark declared $5.10 a share in dividends over the last four quarters and had 333 million shares outstanding at the latest filed count. At 30 September 2026 it carried $6.5 billion of debt and $1.9 billion of cash. At the close of 6 November 2026 the market cap of Kimberly Clark was $36.1 billion, 10.9 times its earnings over the last twelve months.
Read the FY2025 results →the 10-K on EDGAR ↗

Ratios

From the filings

ROE112.6%
ROCE25.6%
Operating margin14.5%
Net margin19.9%
FCF margin11.7%
Interest cover11.0x
Debt to equity2.21x
Cash conversion1.02x
Share count, last 12 months0.2%
Sales CAGR, 3 years-1.0%
Profit CAGR, 3 years1.5%
EPS, TTM$9.91

At the close of 6 November 2026

Price$108.44
Market cap$36.1 billion
Stock P/E10.9x
Price to book12.3x
EV / EBITDA12.9x
Dividend yield4.7%
Market cap / sales2.2x
52-week high$114.74
52-week low$93.05
Price, 1 year7.6%
Price CAGR, 3 years-3.4%
Price CAGR, 5 years-3.9%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the borrowing lines of Kimberly Clark Corp.'s balance sheet, added together, finance leases inside them only where the company puts them there; operating leases are a separate line. Nothing here is a valuation or a view.
KMBgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024 †Q2 FY2024 †Q3 FY2024 †Q4 FY2024Q1 FY2025 †Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue4,9655,0955,0635,0534,9645,1955,1345,1324,9704,3264,2314,1444,1044,0544,1634,1504,0804,1634,1894,134
Cost of revenue3,5293,5753,5343,5103,3373,4693,4033,2943,2333,2382,6372,5803,2532,5452,7072,6572,6152,6292,5862,693
Gross profit1,4361,5201,5291,5431,6271,7261,7311,8381,7371,6861,5941,5641,4451,5091,4561,4931,4651,5341,6031,441
Gross margin29%30%30%31%33%33%34%36%35%39%38%38%35%37%35%36%36%37%38%35%
Operating income5216936216557127871137746708535391,026548631592621507753633516
Operating margin10%14%12%13%14%15%2%15%13%20%13%25%13%16%14%15%12%18%15%12%
Interest expense64.065.068.073.076.073.076.074.070.067.072.067.064.064.067.065.060.058.053.048.0
Pre-tax incomen/an/an/an/an/an/an/an/an/an/a461962n/a557513546436685572471
Tax raten/an/an/an/an/an/an/an/an/an/a13%19%n/a24%23%45%24%24%38%20%
Net income3575234374675075661025875096475449074475675094464996653451,793
Net margin7%10%9%9%10%11%2%11%10%15%13%22%11%14%12%11%12%16%8%43%
Diluted EPS$1.06$1.55$1.29$1.38$1.50$1.67$0.30$1.73$1.50$1.91$1.61$2.69$1.34$1.70$1.53$1.34$1.50$2.00$1.04$5.37
Operating cash flow1,0622047407989916137879271,2154381,021958817327770708972745908755
Capital expenditure273253217209197201188160217194158160209204197340397424352263
Free cash flow789-49.0523589794412599767998244863798608123573368575321556492
Buybacks7.025.024.025.026.030.033.032.013054.010259624861.059.020.01.00.00.00.0
Dividends paid383384391392391391399399399398411411408405419418418418425425
Shares outstanding337m337m338m338m338m337m338m338m337m337m337m334m332m332m332m332m332m332m333m333m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-K10-Q10-Q10-K10-K10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2007FY2008FY2009FY2010FY2011FY2012 †FY2013 †FY2014FY2015FY2016 †FY2017 †FY2018FY2019FY2020FY2021FY2022 †FY2023 †FY2024 †FY2025TTM
Revenue18,26619,41519,11519,74620,84619,46719,56119,72418,59118,28718,34818,48618,45019,14019,44016,95217,14616,80516,44716,566
Cost of revenue12,56213,55712,69513,19614,69413,33812,95213,04111,96711,59611,76112,88912,41512,31813,45211,42810,87710,51610,52410,523
Gross profit5,7045,8586,4206,5506,1526,1296,6096,6836,6246,6916,5875,5976,0356,8225,9885,5246,2696,2895,9236,043
Gross margin31.2%30.2%33.6%33.2%29.5%31.5%33.8%33.9%35.6%36.6%35.9%30.3%32.7%35.6%30.8%32.6%36.6%37.4%36.0%36.5%
Research and developmentn/a297301317316335333368324326309317284276269285303328326n/a
Operating income2,6162,5472,8252,7732,4422,3772,9032,5211,6133,3833,3582,2292,9913,2442,5612,3091,9282,7002,3512,409
Operating margin14.3%13.1%14.8%14.0%11.7%12.2%14.8%12.8%8.7%18.5%18.3%12.1%16.2%16.9%13.2%13.6%11.2%16.1%14.3%14.5%
Interest expense265304275243277285282284295319318263261252256282293270256219
Pre-tax income2,3182,2892,5762,5502,1832,1102,6412,2551,3353,0092,9911,8132,6502,9302,2251,9681,6062,4182,0522,164
Income tax537618746788660660828856418922776471576676479405343442599580
Effective tax rate23.2%27.0%29.0%30.9%30.2%31.3%31.4%38.0%31.3%30.6%25.9%26.0%21.7%23.1%21.5%20.6%21.4%18.3%29.2%26.8%
Net income1,8231,6901,8841,8431,5911,7502,1421,5261,0132,1662,2781,4102,1572,3521,8141,9341,7642,5452,0213,302
Net margin10.0%8.7%9.9%9.3%7.6%9.0%11.0%7.7%5.4%11.8%12.4%7.6%11.7%12.3%9.3%11.4%10.3%15.1%12.3%19.9%
Diluted EPS$4.08$4.03$4.52$4.45$3.99$4.42$5.53$4.04$2.77$5.99$6.40$4.03$6.24$6.87$5.35$5.72$5.21$7.55$6.07$9.91
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K8-K8-K8-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Revenue by segment FY2009 to FY2025, 1 year left out

FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2023FY2024FY2025Share
of the parts, latest year
NAn/an/an/an/an/an/an/an/an/an/an/an/an/a10,99611,01710,75365.4%
IPCn/an/an/an/an/an/an/an/an/an/an/an/an/a5,9405,7435,69434.6%
Consumer Tissue6,4096,4976,7706,5276,6376,6456,1215,9675,9326,0155,9936,7186,034n/an/an/an/a
Corporate and Other-3794881655647394152576467n/an/an/an/a
Health Care1,3711,4601,606n/an/an/an/an/an/an/an/an/an/an/an/an/an/a
K-C Professional and Other3,0073,1103,2943,2833,3233,3883,2193,2353,2973,3823,2923,0193,072n/an/an/an/a
Personal Care8,3658,6709,1289,5769,5369,6359,2049,0469,0789,0379,1089,33910,267n/an/an/an/a
NA FY2023 to FY2025IPC FY2023 to FY2025Personal Care FY2009 to FY2021Consumer Tissue FY2009 to FY2021K-C Professional and Other FY2009 to FY2021Corporate and Other FY2010 to FY2021Health Care FY2009 to FY2011
19.7FY201019.5FY201219.7FY201418.3FY201618.5FY201819.1FY202016.9FY202316.4FY2025

$ billion; hover a block for its figure and share; the figure over a bar is its parts, before the lines named below; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in. Corporate and Other is below zero in FY2009 as the 10-K filed it, so it has no share or block for that year.

Profit by segment FY2009 to FY2025, 1 year left out

The operating profit each segment reports. Costs Kimberly Clark does not charge to a segment are left out, so the segments can add up to more than the company's own operating profit.

FY2009FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2023FY2024FY2025Margin
FY2025
NAn/an/an/an/an/an/an/an/an/an/an/an/an/a2,5142,5422,55323.7%
IPCn/an/an/an/an/an/an/an/an/an/an/an/an/a67382679614.0%
Consumer Tissue7366607758879881,0621,0731,1361,0528751,0071,448888n/an/an/an/a
Corporate and Other-358-293-565-717-381-495-367-245-245-1,112-787-719-559n/an/an/an/a
Health Care244174219n/an/an/an/an/an/an/an/an/an/an/an/an/an/a
K-C Professional and Other464468487542605604590616645634657528404n/an/an/an/a
Personal Care1,7391,7641,5261,6601,6981,8031,8851,8841,9331,8331,9041,9331,856n/an/an/an/a
NA FY2023 to FY2025Personal Care FY2009 to FY2021IPC FY2023 to FY2025Consumer Tissue FY2009 to FY2021K-C Professional and Other FY2009 to FY2021Corporate and Other FY2009 to FY2021Health Care FY2009 to FY2011
2,773FY20102,372FY20122,974FY20143,391FY20162,230FY20183,190FY20203,187FY20233,349FY2025

$ million; the figure over a bar is all the segments together; a year a segment lost money, it hangs below the line. Hover a block for its profit, sales and margin.

FY2025Share of salesShare of profit
NA65%76%
IPC35%24%

Each column adds to 100%. A segment with a bigger share of the profit than of the sales makes more on each dollar it sells.

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where every segment with sales that year has an operating profit figure. A margin is a segment's operating profit over its own sales.

Revenue by product or service FY2017 to FY2025, 1 year left out

FY2017FY2018FY2019FY2020FY2021FY2023FY2024FY2025Share
of the parts, latest year
Baby and Child Care6,3006,3006,3006,4007,2007,0547,0566,77341.2%
Family Caren/an/an/an/an/a4,0243,9284,05624.7%
Adult Caren/an/an/an/an/a1,8091,8641,94711.8%
Professionaln/an/an/an/an/a2,3852,1521,84111.2%
Feminine Caren/an/an/an/an/a1,7871,7211,70610.4%
All Other2,8002,8002,9003,0003,10087841240.8%
Away from Home Professional Products3,3003,4003,3003,0003,100n/an/an/an/a
Consumer Tissue Products5,9006,0006,0006,7006,000n/an/an/an/a
Baby and Child CareFamily Care FY2023 to FY2025Adult Care FY2023 to FY2025Professional FY2023 to FY2025Feminine Care FY2023 to FY2025All OtherConsumer Tissue Products FY2017 to FY2021Away from Home Professional Products FY2017 to FY2021
18.3FY201718.5FY201818.5FY201919.1FY202019.4FY202117.1FY202316.8FY202416.4FY2025

$ billion; hover a block for its figure and share; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

First forecast against the result

Kimberly Clark's EPS landed at or above the top of the range in 2 and inside it in 1 of the 3 years shown (FY2017 to FY2022).

+0.8%FY2017+16.6%FY2019−4.7%FY2022
  • At or above the top of the range
  • Inside the range
  • Under the range

Each bar is the year's result against the top of its first forecast range, in per cent of the top. Hover a bar for the figures.

Fiscal yearFirst forecast
EPS		Result
FY2017$6.20 to $6.35$6.40
FY2019$4.85 to $5.35$6.24
FY2022$5.60 to $6.00$5.72
First forecast
The full-year range the company gave with its fourth-quarter results for the year before, before any later change to it.
Result
The figure the company reported for that year with its next fourth-quarter results.
Years left out
Where the forecast or the result could not be read with confidence. Each figure in the table links to the results release it comes from.

Cash flow

FY2007FY2008FY2009FY2010FY2011FY2012 †FY2013 †FY2014FY2015FY2016 †FY2017 †FY2018FY2019FY2020FY2021FY2022 †FY2023 †FY2024 †FY2025TTM
Operating cash flow2,4292,5163,4812,7442,2883,2883,0402,8452,3063,2322,9292,9702,7363,7292,7302,7333,5423,2342,7773,380
Capital expenditure9899068489649681,0939531,0391,0567717858771,2091,2171,0078767667211,1381,436
Free cash flow1,4401,6102,6331,7801,3202,1952,0871,8061,2502,4612,1442,0931,5272,5121,7231,8572,7762,5131,6391,944
Free cash flow margin7.9%8.3%13.8%9.0%6.3%11.3%10.7%9.2%6.7%13.5%11.7%11.3%8.3%13.1%8.9%11.0%16.2%15.0%10.0%11.7%
Cash from investing-898-847-1,288-781-681-1,184n/an/a-1,050-732-851-902-1,042-2,305-1,056-785-418-100-951-853
Cash from financing-1,427-1,747-1,788-1,859-1,741-1,802n/an/a-1,298-2,185-2,421-2,115-1,792-1,567-1,696-1,760-2,374-3,166-2,179-1,281
Depreciation and amortisation8077757838131,091857863862746705724882917796766754753781805733
Share-based compensation63.047.086.052.048.067.092.052.075.077.076.041.096.014726.0150169131140131
Buybacks2,8136537.08031,2461,2841,2161,9398617399118008007004001002251,0001411.0
Dividends paid9339509861,0661,0991,1511,2231,2561,2721,3111,3591,3861,4081,4511,5161,5581,5881,6281,6601,686
Dividend per sharen/an/an/a$2.64$2.80$2.96$3.24$3.36$3.52$3.68$3.88n/a$4.12$4.28$4.56$4.64$4.72$4.88$5.04n/a
Diluted shares, weightedn/a420m417m414m399m396m387m377m366m362m356m350m346m342m339m338m339m337m333m334m
Shares outstanding at period endn/a414m417m407m396m389m381m365m361m357m351m345m341m339m337m338m337m332m332m333m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K8-K8-K8-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2007FY2008FY2009FY2010FY2011FY2012 †FY2013 †FY2014FY2015FY2016 †FY2017 †FY2018FY2019FY2020FY2021FY2022 †FY2023 †FY2024 †FY2025TTM
Funded by
Shareholders' equityn/a3,8785,4065,9175,2494,9854,856729-174-102629-287-33.06265145479158401,5022,932
Non-controlling interestn/a383284285280302284270214219253241227243223153153135128142
Debtn/an/a5,2955,4646,1326,1855,7616,9567,7757,5727,4257,4557,7478,3648,5748,4227,9847,4187,1686,491
Operating lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/an/a274n/an/an/a293265258n/a
Finance lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a26.032.030.0n/a
Other liabilitiesn/a13,8288,2248,1987,7128,4018,0187,5717,0276,9136,8447,1097,0688,2908,5268,8487,9737,8568,0128,154
Total liabilities and equityn/a18,08919,20919,86419,37319,87318,91915,52614,84214,60215,15114,51815,28317,52317,83717,97017,34416,54617,09817,719
Owned
Fixed assetsn/a7,6678,0338,3568,0498,0957,9487,3597,1047,1697,4367,1597,4508,0428,0977,8856,6056,2846,7757,067
Goodwilln/a2,7433,2753,4033,3403,3373,1811,6281,4461,4801,5761,4741,4671,8951,8401,8801,8941,7961,8391,828
Intangible assetsn/an/a310287265246243109n/an/an/an/a29.083281085118880.077.072.0
Cash and equivalents4733647988767641,1061,0547896199236165394423032704271,0751,0106881,874
Receivablesn/a2,4922,5662,4722,6022,6422,5452,2232,2812,1762,3152,1642,2632,2352,2072,2801,8361,7281,8921,975
Inventoryn/a2,4932,0332,3732,3562,3482,2331,8921,9091,6791,7901,8131,7901,9032,2392,2691,5491,4521,4751,579
Other assetsn/a2,3302,1942,0971,9972,0991,7151,5261,4831,1751,4181,3691,8422,3132,3742,3784,1974,1964,3523,324
Total assetsn/a18,08919,20919,86419,37319,87318,91915,52614,84214,60215,15114,51815,28317,52317,83717,97017,34416,54617,09817,719
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K8-K8-K8-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded-1.2%-3.0%-1.0%0.6%
Profit growth, compounded7.2%-3.0%1.5%67.7%
Return on equity, averagen/a267.4%210.1%134.6%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was Kimberly Clark's revenue in fiscal 2025?

Kimberly Clark (KMB) reported revenue of $16.4 billion for fiscal 2025, the year ended 31 December 2025, down 2.1% on the year before.

How much did Kimberly Clark earn in fiscal 2025?

Net income was $2.0 billion for fiscal 2025, and diluted earnings per share $6.07.

What is Kimberly Clark's P/E ratio?

At the close of 6 November 2026, Kimberly Clark traded at 10.9 times its earnings over the twelve months to 30 September 2026.

What is Kimberly Clark's market cap?

The market cap of Kimberly Clark was $36.1 billion at the close of 6 November 2026.

Does Kimberly Clark pay a dividend?

Yes. Kimberly Clark declared $5.10 a share in dividends over the four quarters to 30 September 2026.

Peers: Business Supplies

CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
Kimberly Clark Corp. KMB$36.1 billion10.94112.6%14.5%0.6%2.214.7%
International Paper Co. IP$21.7 billionn/a-26.3%n/a12.2%0.745.4%
Avery Dennison Corp. AVY$14.1 billion20.2229.7%n/a6.8%1.512.1%
Reynolds Consumer Products Inc. REYN$5.1 billion15.6513.9%n/a2.4%0.663.8%
HNI Corp. HNI$3.4 billion107.412.8%3.0%104.4%0.722.9%
Sylvamo Corp. SLVM$1.6 billionn/a-24.3%5.3%-9.8%1.354.6%
Millerknoll, Inc. MLKN$1.5 billion15.247.2%5.2%1.2%0.963.5%
Mativ Holdings, Inc. MATV$647 million7.2819.6%3.7%-0.4%2.163.4%
Ennis, Inc. EBF$528 million13.6312.4%13.6%2.3%0.004.8%
Magnera Corp. MAGN$442 millionn/an/an/an/a1.87n/a
Rayonier Advanced Materials Inc. RYAM$399 millionn/an/a-17.2%1.9%n/an/a
Ranpak Holdings Corp. PACK$312 millionn/a-6.8%-1.7%8.3%0.79n/a
All 14 in Business Supplies
CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
Kimberly Clark Corp. KMB$36.1 billion10.94112.6%14.5%0.6%2.214.7%
International Paper Co. IP$21.7 billionn/a-26.3%n/a12.2%0.745.4%
Avery Dennison Corp. AVY$14.1 billion20.2229.7%n/a6.8%1.512.1%
Reynolds Consumer Products Inc. REYN$5.1 billion15.6513.9%n/a2.4%0.663.8%
HNI Corp. HNI$3.4 billion107.412.8%3.0%104.4%0.722.9%
Sylvamo Corp. SLVM$1.6 billionn/a-24.3%5.3%-9.8%1.354.6%
Millerknoll, Inc. MLKN$1.5 billion15.247.2%5.2%1.2%0.963.5%
Mativ Holdings, Inc. MATV$647 million7.2819.6%3.7%-0.4%2.163.4%
Ennis, Inc. EBF$528 million13.6312.4%13.6%2.3%0.004.8%
Magnera Corp. MAGN$442 millionn/an/an/an/a1.87n/a
Rayonier Advanced Materials Inc. RYAM$399 millionn/an/a-17.2%1.9%n/an/a
Ranpak Holdings Corp. PACK$312 millionn/a-6.8%-1.7%8.3%0.79n/a
Clearwater Paper Corp. CLW$214 million82.940.3%-1.6%-3.2%0.71n/a
Virco MFG Corporation VIRC$97 millionn/a-2.3%-2.5%-19.0%0.031.6%
2 companies share its SEC industry code (Converted Paper & Paperboard Prods (No Contaners/Boxes)); the rest are the names nearest in size in its wider industry, Business Supplies, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on KMB

Dividends$5.10 a share over the four quarters to 30 September 2026, a 4.70% yield
Filings29 in twelve months: 18 current reports (8-K), about 8 other events; 5 results of operations; 3 officer or director change; 3 regulation FD disclosure; 2 material agreement
Planned insider sales5 Form 144 notices in twelve months, $1.7 million; latest 15 June 2026
Options tapeput/call 0.45 by open interest at the 6 November 2026 close; the straddle prices a 3.6% move to 13 November 2026
13F holders1,724 funds reported a position for the quarter to 30 June 2026; largest BlackRock, Inc.
Insider trading4 sales and 2 purchases on Form 4 in twelve months
Congress1 House trade disclosed in six months
Short interest50.6 million shares short, 10.17 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 5 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q30 September 20265 November 2026EDGAR
10-Q30 June 20264 August 2026EDGAR
10-Q31 March 202628 April 2026EDGAR
10-K31 December 202512 February 2026EDGAR
10-Q30 September 202530 October 2025EDGAR
10-Q30 June 20251 August 2025EDGAR
10-Q31 March 202522 April 2025EDGAR
10-K31 December 202413 February 2025EDGAR
10-Q30 September 202422 October 2024EDGAR
10-Q30 June 202423 July 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.